New Treatment Response in People With and Without Cirrhosis From Chronic Hepatitis C

NCT01888900 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

35

Enrollment

NIH

Sponsor class

Conditions

Cirrhosis
Chronic Hepatitis C
Hepatitis C
Hepatitis C, Chronic

Interventions

DRUG: DUAL
DRUG: QUAD

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Collaborators

[object Object]